Inventor · disambiguated record
Wade Blair
Also filed as: BLAIR WADE · BLAIR WADE S · BLAIR WADE STANTON
6 granted patents·24 pending applications·110 citations·filing 1999–2025
80Inventor score
Files withGRITSTONE BIO INC12GILEAD SCIENCES INC4GRITSTONE ONCOLOGY INC4ASTRAZENECA AB3AGOURON PHARMA2
Top patents by PatentIndex Score
30 records- 0193US6469006B1Antiviral indoleoxoacetyl piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Oct 22, 2002·96 cites·13 claims
- 0292US11807625B2Capsid inhibitors for the prevention of HIVGILEAD SCIENCES INC·Filed 2020·Granted Nov 7, 2023·11 cites·69 claims
- 0389US12109257B2Alphavirus neoantigen vectorsGRITSTONE BIO INC·Filed 2022·Granted Oct 8, 2024·1 cites·20 claims
- 0488US11510973B2Alphavirus antigen vectorsGRITSTONE BIO INC·Filed 2022·Granted Nov 29, 2022·1 cites·57 claims
- 0583US2025249084A1Alphavirus antigen vectorsGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0680US11504421B2Alphavirus neoantigen vectorsGRITSTONE BIO INC·Filed 2018·Granted Nov 22, 2022·1 cites·30 claims
- 0775US2025270192A1Capsid inhibitors for the prevention of hivGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 0872US2024051941A1Capsid inhibitors for the prevention of hivGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 0971US2024067985A1Viral delivery of neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 1070US2025059261A1Multi-specific antigen binding molecules targeting hiv and methods of useGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1169US2025353914A1Antigen-binding proteins and related methods of useGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 1269US2025025544A1Immune checkpoint inhibitor co-expression vectorsGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1368US2023382997A1Antigen-binding proteins targeting shared antigensGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1468US2025270589A1Viral delivery of neoantigensSEATTLE PROJECT CORP·Filed 2025·Application pending·0 cites
- 1565US2023295305A1Antigen-binding proteins and related methods of useGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 1665US2025041400A1Rsv vaccineASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1762US2024277834A1Nucleic acid moleculesASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1862US2024277835A1VaccineASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1958US2023020089A1Shared neoantigen vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2056US2021213122A1Immune checkpoint inhibitor co-expression vectorsGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2152US2021147550A1Antigen-binding proteins targeting shared antigensFRANCIS JOSHUA MICHAEL·Filed 2018·Application pending·0 cites
- 2249US2005112551A1Dual assay for evaluating activity and cytotoxicity of compounds in the same population of cellsAGOURON PHARMA·Filed 2003·Application pending·0 cites
- 2348US2020010849A1Viral delivery of neoantigensGRITSTONE ONCOLOGY INC·Filed 2017·Application pending·0 cites
- 2448US2022213196A1Antigen-binding proteins targeting shared antigensGRITSTONE BIO INC·Filed 2019·Application pending·0 cites
- 2547US2021196806A1Shared antigensGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2643US2005014137A1Lentivirus assay system including Vif protein activityAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 2742US2022162320A1Multispecific binding proteinsGRITSTONE BIO INC·Filed 2020·Application pending·0 cites
- 2838US2021061914A1Antigen-Binding Proteins Targeting Shared AntigensGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 2932US2003013078A1HIV-1 reporter viruses and their use in assaying anti-viral compoundsFiled 2001·Application pending·0 cites
- 3028US6261772B1Method of assaying for RNA: protein interactionsUNIV DUKE·Filed 1999·Granted Jul 17, 2001·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Wade Blair files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →